1017 related articles for article (PubMed ID: 19521197)
21. Platelet activation during hemodialysis measured through exposure of p-selectin: analysis by flow cytometric and ultrastructural techniques.
Reverter JC; Escolar G; Sanz C; Cases A; Villamor N; Nieuwenhuis HK; López J; Ordinas A
J Lab Clin Med; 1994 Jul; 124(1):79-85. PubMed ID: 7518492
[TBL] [Abstract][Full Text] [Related]
22. Enhanced platelet apoptosis in chronic uremic patients.
Li M; Wang Z; Ma T; Lu G; Yan R; Zhao L; Deng K; Dai K
Ren Fail; 2014 Jul; 36(6):847-53. PubMed ID: 24655051
[TBL] [Abstract][Full Text] [Related]
23. Cytoplasmic free calcium mobilization in platelets, expression of P-selectin, phosphatidylserine, and microparticle formation, measured by whole blood flow cytometry, in hypertensive patients. Effect of doxazosin GITS.
Labiós M; Martínez M; Gabriel F; Guiral V; Ruiz-Aja S; Aznar J
Thromb Res; 2006; 117(4):403-9. PubMed ID: 16461073
[TBL] [Abstract][Full Text] [Related]
24. Gray platelet syndrome: alpha-granule deficiency. Its influence on platelet function.
Levy-Toledano S; Caen JP; Breton-Gorius J; Rendu F; Cywiner-Golenzer C; Dupuy E; Legrand Y; Maclouf J
J Lab Clin Med; 1981 Dec; 98(6):831-48. PubMed ID: 6458643
[TBL] [Abstract][Full Text] [Related]
25. Ultrastructural detection of surface exposed phosphatidylserine on activated blood platelets.
Stuart MC; Bevers EM; Comfurius P; Zwaal RF; Reutelingsperger CP; Frederik PM
Thromb Haemost; 1995 Oct; 74(4):1145-51. PubMed ID: 8560427
[TBL] [Abstract][Full Text] [Related]
26. Effect of two different dialysis membranes on leukocyte adhesion and aggregation.
Hernandez MR; Palomo M; Fuste B; Carbó C; Collado S; Cases A; Escolar G
Nephron Clin Pract; 2007; 106(1):c1-8. PubMed ID: 17347577
[TBL] [Abstract][Full Text] [Related]
27. Oxidative stress, sister chromatid exchanges and apoptosis in the pathogenesis of lymphocytopenia in ESRD patients.
Pernice F; Floccari F; Nostro L; Caccamo C; Belghity N; Mantuano S; Romeo A; Barilla' A; Aloisi C; Ruello A; Frisina N; Buemi M
J Nephrol; 2006; 19(5):613-20. PubMed ID: 17136690
[TBL] [Abstract][Full Text] [Related]
28. The role of the extracorporeal circuit in the trapping and degranulation of platelets.
Gritters-van den Oever M; Schoorl M; Schoorl M; Bartels PC; Grooteman MP; Nubé MJ
Blood Purif; 2009; 28(3):253-9. PubMed ID: 19684392
[TBL] [Abstract][Full Text] [Related]
29. Defective platelet beta-N-acetyl hexosaminidase content and release in chronic myeloproliferative disorders.
Emiliani C; Ciferri S; Mencarelli S; Mezzasoma AM; Momi S; Orlacchio A; Gresele P
Platelets; 2006 Feb; 17(1):20-9. PubMed ID: 16308183
[TBL] [Abstract][Full Text] [Related]
30. Platelet abnormalities in idiopathic myelofibrosis: functional, biochemical and immunomorphological correlations.
Leoni P; Rupoli S; Lai G; Brunelli MA; Belmonte MM; Pugnaloni A; Rabini RA; Mazzanti L; Biagini G
Haematologica; 1994; 79(1):29-39. PubMed ID: 15378946
[TBL] [Abstract][Full Text] [Related]
31. Soluble P-selectin during a single hemodialysis session in patients with chronic renal failure and erythropoietin treatment.
Stasko J; Galajda P; Ivanková J; Hollý P; Rozborilová E; Kubisz P
Clin Appl Thromb Hemost; 2007 Oct; 13(4):410-5. PubMed ID: 17911193
[TBL] [Abstract][Full Text] [Related]
32. "In vitro" inhibition of platelet aggregation by uremic middle molecules.
Gallice P; Fournier N; Crevat A; Saingra S; Frayssinet R; Murisasco A; Sicardi F
Biomedicine; 1980; 33(6):185-8. PubMed ID: 7213919
[TBL] [Abstract][Full Text] [Related]
33. [Modification of uremic thrombocytopathy by hemodialysis].
Frick U; Frick G; Vitu J; Wiedenhöft I
Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(2):309-13. PubMed ID: 6194064
[TBL] [Abstract][Full Text] [Related]
34. Plasma annexin A5 and microparticle phosphatidylserine levels are elevated in sickle cell disease and increase further during painful crisis.
van Tits LJ; van Heerde WL; Landburg PP; Boderie MJ; Muskiet FA; Jacobs N; Duits AJ; Schnog JB
Biochem Biophys Res Commun; 2009 Dec; 390(1):161-4. PubMed ID: 19799864
[TBL] [Abstract][Full Text] [Related]
35. Detection of activated platelets in canine blood by use of flow cytometry.
Wills TB; Wardrop KJ; Meyers KM
Am J Vet Res; 2006 Jan; 67(1):56-63. PubMed ID: 16426212
[TBL] [Abstract][Full Text] [Related]
36. Merocyanine 540 as a fluorescent probe of altered membrane phospholipid asymmetry in activated whole blood platelets.
Watala C; Waczulikova I; Wieclawska B; Rozalski M; Gresner P; Gwoździński K; Mateasik A; Sikurova L
Cytometry; 2002 Nov; 49(3):119-33. PubMed ID: 12442312
[TBL] [Abstract][Full Text] [Related]
37. [Evaluation of thrombotic risk in type 2 diabetes: determination of platelet factor 4 and beta thromboglobulin].
Diop S; Ka-Cisse M; Toure-Fall AO; Diagne Fall-Sarr F; Diop SN; Thiam D; Diakhate L
Dakar Med; 2002; 47(2):247-51. PubMed ID: 15776686
[TBL] [Abstract][Full Text] [Related]
38. Flow cytometric assessment of platelet function in patients with peripheral arterial occlusive disease.
Galt SW; McDaniel MD; Ault KA; Mitchell J; Cronenwett JL
J Vasc Surg; 1991 Dec; 14(6):747-55; discussion 755-6. PubMed ID: 1720468
[TBL] [Abstract][Full Text] [Related]
39. Nucleotide deficit and functional platelet alterations in patients on regular dialysis treatment (RDT).
Albertazzi A; Spisni C; Palmieri PF; Ruzzi L; Di Guglielmo R; Di Filippo L; Evangelista M
Life Support Syst; 1985; 3 Suppl 1():77-81. PubMed ID: 3870626
[TBL] [Abstract][Full Text] [Related]
40. Secreted platelet proteins with antiheparin and mitogenic activities in chronic renal failure.
Guzzo J; Niewiarowski S; Musial J; Bastl C; Grossman RA; Rao AK; Berman I; Paul D
J Lab Clin Med; 1980 Jul; 96(1):102-13. PubMed ID: 6446588
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
